387 related articles for article (PubMed ID: 34885733)
21. Differential effect of finasteride on the tissue androgen concentrations in benign prostatic hyperplasia.
Habib FK; Ross M; Tate R; Chisholm GD
Clin Endocrinol (Oxf); 1997 Feb; 46(2):137-44. PubMed ID: 9135694
[TBL] [Abstract][Full Text] [Related]
22. [Dihydrotestosterone and the role of 5 alpha-reductase inhibitors in benign prostatic hyperplasia].
Bartsch G; Rittmaster RS; Klocker H
Urologe A; 2002 Sep; 41(5):412-24. PubMed ID: 12426858
[TBL] [Abstract][Full Text] [Related]
23. Serenoa repens extracts: In vitro study of the 5α-reductase activity in a co-culture model for Benign Prostatic Hyperplasia.
Buonocore D; Verri M; Cattaneo L; Arnica S; Ghitti M; Dossena M
Arch Ital Urol Androl; 2018 Sep; 90(3):199-202. PubMed ID: 30362688
[TBL] [Abstract][Full Text] [Related]
24. Potency of a novel saw palmetto ethanol extract, SPET-085, for inhibition of 5alpha-reductase II.
Pais P
Adv Ther; 2010 Aug; 27(8):555-63. PubMed ID: 20623347
[TBL] [Abstract][Full Text] [Related]
25. Ulmus macrocarpa Hance improves benign prostatic hyperplasia by regulating prostatic cell apoptosis.
Rho J; Seo CS; Park HS; Wijerathne CU; Jeong HY; Moon OS; Seo YW; Son HY; Won YS; Kwun HJ
J Ethnopharmacol; 2019 Apr; 233():115-122. PubMed ID: 30508623
[TBL] [Abstract][Full Text] [Related]
26. Effects of different natural extracts in an experimental model of benign prostatic hyperplasia (BPH).
Paterniti I; Campolo M; Cordaro M; Siracusa R; Filippone A; Esposito E; Cuzzocrea S
Inflamm Res; 2018 Jul; 67(7):617-626. PubMed ID: 29679313
[TBL] [Abstract][Full Text] [Related]
27. Saw palmetto and benign prostatic hyperplasia.
Gong EM; Gerber GS
Am J Chin Med; 2004; 32(3):331-8. PubMed ID: 15344416
[TBL] [Abstract][Full Text] [Related]
28. A preliminary investigation of the enzymatic inhibition of 5alpha-reduction and growth of prostatic carcinoma cell line LNCap-FGC by natural astaxanthin and Saw Palmetto lipid extract in vitro.
Anderson ML
J Herb Pharmacother; 2005; 5(1):17-26. PubMed ID: 16093232
[TBL] [Abstract][Full Text] [Related]
29. Effects of Lespedeza Cuneata aqueous extract on testosterone-induced prostatic hyperplasia.
Park BK; Kim CW; Kwon JE; Negi M; Koo YT; Lee SH; Baek DH; Noh YH; Kang SC
Pharm Biol; 2019 Dec; 57(1):90-98. PubMed ID: 30724641
[TBL] [Abstract][Full Text] [Related]
30. [Status of phytotherapeutic drugs in treatment of benign prostatic hyperplasia].
Dreikorn K; Schönhöfer PS
Urologe A; 1995 Mar; 34(2):119-29. PubMed ID: 7538709
[TBL] [Abstract][Full Text] [Related]
31. A review of animal and human studies for management of benign prostatic hyperplasia with natural products: perspective of new pharmacological agents.
Azimi H; Khakshur AA; Aghdasi I; Fallah-Tafti M; Abdollahi M
Inflamm Allergy Drug Targets; 2012 Jun; 11(3):207-21. PubMed ID: 22512478
[TBL] [Abstract][Full Text] [Related]
32. Combination of Ligustri Lucidi Fructus with Ecliptae Herba and their phytoestrogen or phytoandrogen like active pharmaceutical ingredients alleviate oestrogen/testosterone-induced benign prostatic hyperplasia through regulating steroid 5-α-reductase.
Tao R; Liu E; Zhao X; Han L; Yu B; Mao H; Yang W; Gao X
Phytomedicine; 2022 Jul; 102():154169. PubMed ID: 35636178
[TBL] [Abstract][Full Text] [Related]
33. Extracts from fruits of saw palmetto (Sabal serrulata) and roots of stinging nettle (Urtica dioica): viable alternatives in the medical treatment of benign prostatic hyperplasia and associated lower urinary tracts symptoms.
Koch E
Planta Med; 2001 Aug; 67(6):489-500. PubMed ID: 11509966
[TBL] [Abstract][Full Text] [Related]
34. A double blind, placebo-controlled randomized comparative study on the efficacy of phytosterol-enriched and conventional saw palmetto oil in mitigating benign prostate hyperplasia and androgen deficiency.
Sudeep HV; Thomas JV; Shyamprasad K
BMC Urol; 2020 Jul; 20(1):86. PubMed ID: 32620155
[TBL] [Abstract][Full Text] [Related]
35. Therapeutic effect of D-004, a lipid extract from Roystonea regia fruits, on prostate hyperplasia induced in rats.
Carbajal D; Molina V; Mas R; Arruzazabala ML
Drugs Exp Clin Res; 2005; 31(5-6):193-7. PubMed ID: 16425975
[TBL] [Abstract][Full Text] [Related]
36. Serenoa repens for Lower Urinary Tract Symptoms/Benign Prostatic Hyperplasia: Current Evidence and Its Clinical Implications in Naturopathic Medicine.
Ooi SL; Pak SC
J Altern Complement Med; 2017 Aug; 23(8):599-606. PubMed ID: 28436684
[TBL] [Abstract][Full Text] [Related]
37. Combined sabal and urtica extract compared with finasteride in men with benign prostatic hyperplasia: analysis of prostate volume and therapeutic outcome.
Sökeland J
BJU Int; 2000 Sep; 86(4):439-42. PubMed ID: 10971268
[TBL] [Abstract][Full Text] [Related]
38. Amelioration of testosterone induced benign prostatic hyperplasia by Prunus species.
Jena AK; Vasisht K; Sharma N; Kaur R; Dhingra MS; Karan M
J Ethnopharmacol; 2016 Aug; 190():33-45. PubMed ID: 27235020
[TBL] [Abstract][Full Text] [Related]
39. Extracts of
Song KH; Seo CS; Yang WK; Gu HO; Kim KJ; Kim SH
Nutrients; 2021 Mar; 13(3):. PubMed ID: 33803357
[TBL] [Abstract][Full Text] [Related]
40. A possible case of saw palmetto-induced pancreatitis.
Wargo KA; Allman E; Ibrahim F
South Med J; 2010 Jul; 103(7):683-5. PubMed ID: 20531057
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]